Colorectal cancer (CRC) patients with Kristen rat sarcoma viral gene (KRAS) mutant tumors are associated with lack of response to anti-epidermal growth factor receptor (anti-EGFR) antibody therapy [6–10]. Here, KRAS is linked to colorectal cancer.